GE HealthCare Technologies Inc
For the period ended Dec 31, 2024. Filed Feb 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 13, 2025
GEHC$83.65-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated and Combined Statements of Changes in Equity
| Consolidated and Combined Statements of Changes in Equity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Common stock · Treasury stock | ||||||||||
| (In millions, except per share amounts) | Shares | Amount | Shares | Amount | Additional paid-in capital | Retained earnings | Net parent investment | Accumulated other comprehensive income (loss) – net | Equity attributable to noncontrolling interests | Total equity |
| Balances as of December 31, 2021 | — | $— | — | $— | $— | $— | $17,692 | $(1,037) | $21 | $16,676 |
| Net income attributable to GE HealthCare | — | — | — | — | — | — | 1,916 | — | — | 1,916 |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | — | (841) | — | (841) |
| Transfers (to) from GE | — | — | — | — | — | — | (8,373) | — | — | (8,373) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | (16) | (16) |
| Balances as of December 31, 2022 | — | — | — | — | — | — | 11,235 | (1,878) | 5 | 9,362 |
| Net transfers from GE, including Spin-Off-related adjustments | — | — | — | — | — | — | (4,851) | 2,000 | 2 | (2,849) |
| Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment | 454 | 5 | — | — | 6,379 | — | (6,384) | — | — | — |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 1 | — | — | — | — | — | — | — | — | — |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,568 | — | — | — | 1,568 |
| Dividends declared ($0.12 per common share) | — | — | — | — | — | (55) | — | — | — | (55) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | — | (813) | — | (813) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | 5 | 5 |
| Share-based compensation | — | — | — | — | 114 | — | — | — | — | 114 |
| Changes in equity due to redemption value adjustments on redeemable noncontrolling interests | — | — | — | — | — | (187) | — | — | — | (187) |
| Balances as of December 31, 2023 | 455 | 5 | — | — | 6,493 | 1,326 | — | (691) | 12 | 7,145 |
| Issuance of shares under equity awards, net of shares withheld for taxes and other | 2 | — | — | (25) | (35) | — | — | — | — | (60) |
| Net income attributable to GE HealthCare | — | — | — | — | — | 1,993 | — | — | — | 1,993 |
| Dividends declared ($0.125 per common share) | — | — | — | — | — | (58) | — | — | — | (58) |
| Other comprehensive income (loss) attributable to GE HealthCare | — | — | — | — | — | — | — | (688) | — | (688) |
| Changes in equity attributable to noncontrolling interests | — | — | — | — | — | — | — | — | 7 | 7 |
| Share-based compensation | — | — | — | — | 125 | — | — | — | — | 125 |
| Balances as of December 31, 2024 | 457 | $5 | — | $(25) | $6,583 | $3,262 | $— | $(1,379) | $18 | $8,464 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.